Adalimumab in Axial Spondyloarthritis (ASIM) - MRI and Biomarkers in Patients With Spondyloarthritis

NCT01029847 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Spondyloarthritis

Interventions

DRUG: Adalimumab
DRUG: Placebo

Sponsor

Rigshospitalet, Denmark